These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26863504)

  • 1. Targeting the glial-derived neurotrophic factor and related molecules for controlling normal and pathologic pain.
    Merighi A
    Expert Opin Ther Targets; 2016; 20(2):193-208. PubMed ID: 26863504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small Molecules and Peptides Targeting Glial Cell Line-Derived Neurotrophic Factor Receptors for the Treatment of Neurodegeneration.
    Sidorova YA; Saarma M
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson's disease.
    Mahato AK; Sidorova YA
    Cell Tissue Res; 2020 Oct; 382(1):147-160. PubMed ID: 32556722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GDNF family receptor complexes are emerging drug targets.
    Bespalov MM; Saarma M
    Trends Pharmacol Sci; 2007 Feb; 28(2):68-74. PubMed ID: 17218019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential].
    Sidorova YA; Saarma M
    Mol Biol (Mosk); 2016; 50(4):589-598. PubMed ID: 27668599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain.
    Sakai A; Asada M; Seno N; Suzuki H
    Pain; 2008 Jul; 137(2):378-388. PubMed ID: 17967506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel RET agonist for the treatment of experimental neuropathies.
    Viisanen H; Nuotio U; Kambur O; Mahato AK; Jokinen V; Lilius T; Li W; Santos HA; Karelson M; Rauhala P; Kalso E; Sidorova YA
    Mol Pain; 2020; 16():1744806920950866. PubMed ID: 32811276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain.
    Kimura M; Sakai A; Sakamoto A; Suzuki H
    Br J Pharmacol; 2015 May; 172(10):2469-78. PubMed ID: 25572945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycan syndecan-3 is a novel receptor for GDNF, neurturin, and artemin.
    Bespalov MM; Sidorova YA; Tumova S; Ahonen-Bishopp A; Magalhães AC; Kulesskiy E; Paveliev M; Rivera C; Rauvala H; Saarma M
    J Cell Biol; 2011 Jan; 192(1):153-69. PubMed ID: 21200028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons
    Sidorova YA; Bespalov MM; Wong AW; Kambur O; Jokinen V; Lilius TO; Suleymanova I; Karelson G; Rauhala PV; Karelson M; Osborne PB; Keast JR; Kalso EA; Saarma M
    Front Pharmacol; 2017; 8():365. PubMed ID: 28680400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells.
    Lee RH; Wong WL; Chan CH; Chan SY
    J Neurosci Res; 2006 Jan; 83(1):80-90. PubMed ID: 16294336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of GFRalpha-1 expression by antisense oligodeoxynucleotide attenuates electroacupuncture analgesia on heat hyperalgesia in a rat model of neuropathic pain.
    Dong ZQ; Ma F; Xie H; Wang YQ; Wu GC
    Brain Res Bull; 2006 Mar; 69(1):30-6. PubMed ID: 16464682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of GDNF family ligands and receptors in the carotid body.
    Leitner ML; Wang LH; Osborne PA; Golden JP; Milbrandt J; Johnson EM
    Exp Neurol; 2005 Feb; 191 Suppl 1():S68-79. PubMed ID: 15629763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Other neurotrophic factors: glial cell line-derived neurotrophic factor (GDNF).
    Saarma M; Sariola H
    Microsc Res Tech; 1999 May 15-Jun 1; 45(4-5):292-302. PubMed ID: 10383122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial Cell Line-Derived Neurotrophic Factor Family Ligands, Players at the Interface of Neuroinflammation and Neuroprotection: Focus Onto the Glia.
    Kotliarova A; Sidorova YA
    Front Cell Neurosci; 2021; 15():679034. PubMed ID: 34220453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is GAS1 a co-receptor for the GDNF family of ligands?
    Schueler-Furman O; Glick E; Segovia J; Linial M
    Trends Pharmacol Sci; 2006 Feb; 27(2):72-7. PubMed ID: 16406089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GDNF Family: A Role in Cancer?
    Fielder GC; Yang TW; Razdan M; Li Y; Lu J; Perry JK; Lobie PE; Liu DX
    Neoplasia; 2018 Jan; 20(1):99-117. PubMed ID: 29245123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of N-cadherin-β-catenin signaling on the analgesic effects of glial cell-derived neurotrophic factor in neuropathic pain.
    Pan Y; Jiang L; Wang C
    Biochem Biophys Res Commun; 2020 Feb; 522(2):463-470. PubMed ID: 31780260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GDNF, Neurturin, and Artemin Activate and Sensitize Bone Afferent Neurons and Contribute to Inflammatory Bone Pain.
    Nencini S; Ringuet M; Kim DH; Greenhill C; Ivanusic JJ
    J Neurosci; 2018 May; 38(21):4899-4911. PubMed ID: 29712778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma membrane localization of the GFL receptor components: a nexus for receptor crosstalk.
    Donnelly CR; Pierchala BA
    Cell Tissue Res; 2020 Oct; 382(1):57-64. PubMed ID: 32767110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.